Rezolute (RZLT) Change in Accured Expenses (2012 - 2026)
Rezolute recorded quarterly Change in Accured Expenses of -$1.4 million in Q1 2026, down 2.23% quarter-over-quarter from -$1.4 million in Q4 2025, and up 60.66% year-over-year from -$883232.6 in Q1 2025.
Rezolute's Change in Accured Expenses history runs 15 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 60.66% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$238000.0 (down 158.7% YoY), while the FY2025 annual figure was $721000.0, down 66.4% from the prior year.
- Change in Accured Expenses came in at -$1.4 million for Q1 2026 at Rezolute, down from -$1.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q3 2023 to a low of -$3.6 million in Q1 2025.
- A 5-year average of $3058.8 and a median of -$42000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses tumbled 275.0% in 2022 and surged 6550.0% in 2023, its largest moves.
- Rezolute's Change in Accured Expenses stood at $2.1 million in 2022, then sank by 125.74% to -$540000.0 in 2023, then soared by 373.7% to $1.5 million in 2024, then tumbled by 193.91% to -$1.4 million in 2025, then slipped by 2.23% to -$1.4 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, -$1.4 million, and $667000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | 667,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 948,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | -540,000.00 |
| Dec 31, 2023 | -540,000.00 |
| Sep 30, 2023 | 2.71 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 373,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | -2.22 Mn |
| Mar 31, 2023 | -2.22 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | -42,000.00 |
| Sep 30, 2022 | -42,000.00 |
| Jun 30, 2022 | -78,000.00 |
| Jun 30, 2022 | -78,000.00 |
| Mar 31, 2022 | -802,000.00 |
| Mar 31, 2022 | -802,000.00 |
| Dec 31, 2021 | 1.09 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 24,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | -1.24 Mn |
| Mar 31, 2021 | -1.24 Mn |
| Dec 31, 2020 | 1.39 Mn |
| Dec 31, 2020 | 1.39 Mn |
| Sep 30, 2020 | -195,000.00 |
| Sep 30, 2020 | -195,000.00 |
| Jun 30, 2020 | -11,000.00 |
| Jun 30, 2020 | -11,000.00 |
| Mar 31, 2020 | -970,000.00 |
| Mar 31, 2020 | -970,000.00 |
| Dec 31, 2019 | 854,000.00 |
| Dec 31, 2019 | 854,000.00 |
| Sep 30, 2019 | -1.02 Mn |
| Sep 30, 2019 | -1.02 Mn |
| Mar 31, 2019 | -66,000.00 |
| Mar 31, 2019 | -66,000.00 |
| Dec 31, 2018 | 512,000.00 |
| Dec 31, 2018 | 512,000.00 |
| Sep 30, 2018 | 209,000.00 |
| Sep 30, 2018 | 209,000.00 |
| Jun 30, 2018 | -761,496.00 |
| Jun 30, 2018 | -761,496.00 |
| Mar 31, 2018 | 1.48 Mn |
| Mar 31, 2018 | 1.48 Mn |
| Jun 30, 2017 | 115,147.00 |
| Jun 30, 2017 | 115,147.00 |
| Mar 31, 2017 | -14,897.00 |
| Mar 31, 2017 | -14,897.00 |
| Dec 31, 2016 | 285,734.00 |
| Dec 31, 2016 | 285,734.00 |
| Sep 30, 2016 | -273,637.00 |
| Sep 30, 2016 | -273,637.00 |
| Jun 30, 2016 | 500.00 |
| Jun 30, 2016 | 500.00 |
| Mar 31, 2016 | -294,465.00 |
| Mar 31, 2016 | -294,465.00 |
| Dec 31, 2015 | 295,465.00 |
| Dec 31, 2015 | 295,465.00 |
| Sep 30, 2015 | 500.00 |
| Sep 30, 2015 | 500.00 |
| Jun 30, 2015 | -378,727.00 |
| Jun 30, 2015 | -378,727.00 |
| Mar 31, 2015 | 379,727.00 |
| Mar 31, 2015 | 379,727.00 |
| Dec 31, 2014 | 141,197.00 |
| Dec 31, 2014 | 141,197.00 |
| Sep 30, 2014 | -140,197.00 |
| Sep 30, 2014 | -140,197.00 |
| Jun 30, 2014 | -185,385.00 |
| Jun 30, 2014 | -185,385.00 |
| Mar 31, 2014 | 236,466.00 |
| Mar 31, 2014 | 236,466.00 |
| Dec 31, 2013 | 346.00 |
| Dec 31, 2013 | 346.00 |
| Sep 30, 2013 | 220,538.00 |
| Sep 30, 2013 | 220,538.00 |
| Jun 30, 2013 | 82,052.00 |
| Jun 30, 2013 | 82,052.00 |
| Mar 31, 2013 | -157,967.00 |
| Mar 31, 2013 | -157,967.00 |
| Dec 31, 2012 | 165,453.00 |
| Dec 31, 2012 | 165,453.00 |
| Sep 30, 2012 | 180,913.00 |
| Sep 30, 2012 | 180,913.00 |
| Jun 30, 2012 | 58,307.00 |
| Jun 30, 2012 | 58,307.00 |
| Mar 31, 2012 | 54,875.00 |
| Mar 31, 2012 | 54,875.00 |